Munich, Germany – December 1, 2000 – Bicoll GmbH has been founded in Munich, Germany, one of
Europe’s most interesting biotech “hotspots”. Bicoll’s mission is to accelerate the developing process
of new drug candidates.
The growing biotechnology company provides an innovative, flexible and fast concept for modern
drug research. Bicoll provides experienced manpower and the required expertise in defined research
fields. By combining research in combinatorial chemistry, screening techniques, natural product
chemistry and synthesis Bicoll is able to embrace a leading position in drug development. With its
proprietary techniques, such as BIFRAC N, Bicoll will create a vast number of pharmaceutical like
compounds available for high-throughput bioassays. Moreover Bicoll launches into proprietary
projects involving development and optimization of new drug candidates.